TSHA EPS Estimates
Taysha Gene Therapies, Inc.
$3.72
+$0.21(+5.84%)
41
Overall
55
Value
18
Tech
50
Quality
Market Cap
$1.14B
Volume
670.82K
52W Range
$3.69 - $7.30
Target Price
$13.00
TSHA EPS estimates: the consensus estimate for Taysha Gene Therapies, Inc.'s current fiscal year is -$0.52 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TSHA EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.14
- EPS estimate, current year
- $-0.52
- EPS estimate, next year
- $-0.49
- EPS growth, 3-year
- +55.19%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.34 |
| 2024 | $-0.36 |
| 2023 | $-0.96 |
| 2022 | $-3.78 |
| 2021 | $-4.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $3.72 | +5.8% | 670.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW